Photo of Kenneth Alan Freedberg, MD

Kenneth Alan Freedberg, MD


Accepting New Patients: Call for Availability



Infectious Diseases


Clinical Interests
  • AIDS and HIV infection
  • Infectious diseases
Medical Education
  • MD, Harvard Medical School
  • Residency, Beth Israel Deaconess Medical Center
  • Fellowship, Beth Israel Deaconess Medical Center
Board Certifications
  • Internal Medicine
Foreign Languages
  • French
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • AllWays Health (NHP) - ACD
  • AllWays Health (NHP) - PBO
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Maine Community Health Options (MCHO)
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Provider Gender


Kenneth A. Freedberg, MD, is Professor of Medicine at Harvard Medical School and Massachusetts General Hospital and Director of the Program in Epidemiology and Outcomes Research at the Harvard University Center for AIDS Research (CFAR). He also directs the Medical Practice Evaluation Center within the Department of Medicine at Massachusetts General Hospital.

Research & Publications

Research Summary

Dr. Freedberg's research interests focus on HIV, TB, as well as other chronic disease clinical outcomes and health policy, utilizing the methods of comparative effectiveness, cost-effectiveness analysis, clinical epidemiology, and implementation science. He is most interested in the intersection of clinical medicine and economics - to understand the "value" of health care.

His current research efforts are focused in the United States, France, Portugal, Brazil, South Africa, Cote d'Ivoire, Zimbabwe, Botswana, Mozambique and India. This NIH and foundation-funded work examines clinical policies for antiretroviral use, HIV testing, laboratory management, and HIV/TB co-infection.

The Medical Practice Evaluation Center team has a particular interest in informing guidelines in individual countries and across regions in both well-resourced and resource-limited settings. Collaborators include investigators in each of the countries above, as well as in HIV trials groups in the United States including the ACTG, IMPAACT, and the HPTN.


View my most recent publications at PubMed

News & Events

  • State-of-the-art HIV drug could curb HIV transmission, improve survival in India

    As study led by a Massachusetts General Hospital research team finds that an HIV treatment regimen widely used in North America and Europe would likely increase the life expectancy of people living with HIV in India and reduce the number of new HIV infections with minimal impact on the country’s HIV/AIDS budget.

  • Achieving National HIV/AIDS Strategy targets would save lives, be cost effective

    An analysis led by a team of Massachusetts General Hospital investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value.

  • Early HIV antiviral treatment found to be cost-effective in South Africa, India

    "Treatment as prevention" – early initiation of antiretroviral therapy (ART) for HIV-infected individuals with uninfected sexual partners to prevent viral transmission – appears to make economic sense, along with meeting its clinical goals of helping infected patients stay healthy and reducing transmission.

  • How can pediatric HIV be eliminated in Zimbabwe?

    Eliminating new infant HIV infections in Zimbabwe will require not only improved access to antiretroviral medications but also support to help HIV-infected mothers continue taking their medication and safely reduce or eliminate breastfeeding, according to study led by MGH investigators.

  • Andrea Ciaranello, MD, MPH, and Kenneth A. Freedberg, MD, MSc, honored

    MGH Hotline 010909 Andrea Ciaranello, MD, MPH, of the MGH Infectious Disease Unit; and Kenneth A. Freedberg, MD, MSc, director of the MGH HIV Research Program in the Division of General Medicine, have received a grant from the Elizabeth Glaser Pediatric AIDS Foundation to study best practices in the fight against pediatric AIDS.


Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-8597
Fax: 617-726-7653
Medical Walk In Unit
15 Parkman Street
Boston, MA 02114-3117
Phone: 617-726-2707

Back to Top